Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
The anti-proliferative and anti-angiogenic effect of the methanol extract from brittle star.
Baharara J
,
Amini E
,
Mousavi M
.
???displayArticle.abstract???
BACKGROUND: Anti-angiogenic therapy is a crucial step in cancer treatment. The discovery of new anti-angiogenic compounds from marine organisms has become an attractive concept in anti-cancer therapy. Because little data correlated to the pro- and anti-angiogenic efficacies of Ophiuroidea, which include brittle star, the current study was designed to explore the anti-angiogenic potential of brittle star methanol extract in vitro and in vivo.
METHODS: The anti-proliferative effect of brittle star extract on A2780cp cells was examined by MTT assays, and transcriptional expression of VEGF and b-FGF was evaluated by RT-PCR. In an in vivo model, 40 fertilized Ross eggs were divided into control and three experimental groups. The experimental groups were incubated with brittle star extract at concentrations of 25, 50 and 100 µg/ml, and photographed by photo-stereomicroscopy. Ultimately, numbers and lengths of vessels were measured by Image J software. Data were analyzed with SPSS software (p<0.05).
RESULTS: Results illustrated that the brittle star extract exerted a dose- and time-dependent anti-proliferative effect on A2780cp cancer cells. In addition, VEGF and b-FGF expression decreased with brittle star methanol extract treatment. Macroscopic evaluations revealed significant changes in the second and third experimental group compared to controls (p<0.05).
CONCLUSION: These finding revealed the anti-angiogenic effects of brittle star methanol extract in vitro and in vivo confer novel insight into the application of natural marine products in angiogenesis-related pathologies.
Cao,
Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants.
2005, Pubmed
Cao,
Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants.
2005,
Pubmed
Edwards,
Animal models for anti-angiogenic therapy in endometriosis.
2013,
Pubmed
Elice,
Side effects of anti-angiogenic drugs.
2012,
Pubmed
Fan,
Angiogenesis: from plants to blood vessels.
2006,
Pubmed
Gacche,
Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
2014,
Pubmed
He,
Anti-angiogenic effects of rhubarb and its anthraquinone derivatives.
2009,
Pubmed
He,
Anti-angiogenic effects of the fruit of Alpinia oxyphylla.
2010,
Pubmed
He,
Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei.
2011,
Pubmed
He,
Anti-angiogenic effects and mechanisms of zerumin A from Alpinia caerulea.
2012,
Pubmed
Hua,
Anti-angiogenic activity of julibroside J8, a natural product isolated from Albizia julibrissin.
2009,
Pubmed
Huang,
Anti-angiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells.
2013,
Pubmed
Jiang,
Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
2013,
Pubmed
Jung,
Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of an ethanol extract of Salvia plebeia R. Brown.
2009,
Pubmed
Kumaran,
Antiangiogenic drugs in ovarian cancer.
2009,
Pubmed
Lee,
Anti-angiogenic activity of methanol extract of Phellinus linteus and its fractions.
2010,
Pubmed
Lieu,
Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.
2011,
Pubmed
Masoumi Moghaddam,
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.
2012,
Pubmed
Mojzis,
Antiangiogenic effects of flavonoids and chalcones.
2008,
Pubmed
Namvar,
Antioxidant, antiproliferative, and antiangiogenesis effects of polyphenol-rich seaweed (Sargassum muticum).
2013,
Pubmed
Park,
The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
2009,
Pubmed
Potente,
Basic and therapeutic aspects of angiogenesis.
2011,
Pubmed
Rhode,
Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells.
2007,
Pubmed
Varinska,
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
2012,
Pubmed
Yi,
Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo.
2012,
Pubmed
Yoo,
Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Saururus chinensis extract.
2008,
Pubmed
Zhu,
Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis.
2005,
Pubmed
Zulato,
Metabolic effects of anti-angiogenic therapy in tumors.
2012,
Pubmed
